| GlaxoSmithKline AG - Wellvone, Suspension | | 53563 | | 01 | | Wellvone | | Suspension | | P01AX06 | | Atovaquone | | 29.05.1996 | | |
| | Composition | | atovaquonum 750 mg, alcohol benzylicus 50 mg, xanthani gummi, poloxamerum 188, saccharinum natricum corresp. natrium 0.95 mg, aromatica (Vielfrucht) cum aurantii dulcis aetheroleum, aurantii dulcis aetheroleum concentratum, propylenglycolum, alcohol benzylicus 0.66 mg, vanillinum, acetaldehydum, ethylis butyras et amylis acetas, aqua purificata q.s. ad suspensionem pro 5 ml. | | Packungsbestandteile | | Suspension | | | | | | | | Active Agent | Dose |
|---|
| Atovaquone | 750mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Atovaquone | 750 mg |
| | | | Inactive agents | Dose |
|---|
| Acetaldehydum | | | Alcohol Benzylicus | 0.66mg / 5ml | | Amylis Acetas | | | Aqua Purificata | | | Aromatica (Vielfrucht) cum Aurantii Dulcis Aetheroleum | | | Aurantii Dulcis Aetheroleum Concentratum | | | Ethylis Butyras | | | Poloxamer | 188 | | Propylenglycol | | | Saccharinum Natricum | | | Vanilline | | | Xanthani Gummi | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 015 | 210 ml | 432.15 | 486.40 | A | SL | Yes |
|
|
